Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Ambinder

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Hematologic Pathology|January 1, 1995
Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistryP G Murray, E Deacon, L S Young, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 1999
Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissueJ R Schroeder, A J Saah, R F Ambinder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphomaJ G Berdeja, R J Jones, M L Zahurak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's diseaseR J Jones, S Piantadosi, R B Mann, et al.
The New England Journal of Medicine|June 16, 1983
Acyclovir halts progression of herpes zoster in immunocompromised patientsH H Balfour, B Bean, O L Laskin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 1999
Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphomaJ R Schroeder, A J Saah, D R Hoover, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphomaD Y Song, R J Jones, J S Welsh, et al.
Oncogene|January 11, 2011
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumorsJ S W Low, Q Tao, K M Ng, et al.
Human Pathology|September 22, 2001
Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomasP G Murray, L J Swinnen, J R Flavell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphomaY L Kasamon, R J Jones, R A Brodsky, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Hematologic Pathology|January 1, 1995
Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistryP G Murray, E Deacon, L S Young, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 1999
Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissueJ R Schroeder, A J Saah, R F Ambinder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphomaJ G Berdeja, R J Jones, M L Zahurak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's diseaseR J Jones, S Piantadosi, R B Mann, et al.
The New England Journal of Medicine|June 16, 1983
Acyclovir halts progression of herpes zoster in immunocompromised patientsH H Balfour, B Bean, O L Laskin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 1999
Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphomaJ R Schroeder, A J Saah, D R Hoover, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphomaD Y Song, R J Jones, J S Welsh, et al.
Oncogene|January 11, 2011
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumorsJ S W Low, Q Tao, K M Ng, et al.
Human Pathology|September 22, 2001
Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomasP G Murray, L J Swinnen, J R Flavell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphomaY L Kasamon, R J Jones, R A Brodsky, et al.
Pageof 11